Discover how oral small molecule GLP‑1 receptor agonists could replace weekly injections like semaglutide and tirzepatide, offering scalable, room‑temperature‑stable pills that transform obesity and type 2 diabetes care worldwide.
Explore how machine learning and generative AI are revolutionizing small molecule drug discovery—from data-driven design and ADMET prediction to generative models that “imagine” new drugs and reshape modern pharmacology.